MissionIR Articles
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced its participation in the H.C. Wainwright Global Investment Conference, which is taking place Sept. 11-13, 2023, in New York City. The on-demand presentation by InMed’s CEO Eric A. Adams will be available beginning…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Receives Delisting Notification from NASDAQ, Files an Appeal
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received a letter from the Listing Qualifications Department of the NASDAQ Stock Market. The letter notes that MULN did not meet the deadline to regain compliance with NASDAQ listing requirements; the deadline was Sept. 5, 2023. According to the notice, the company failed to…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs Deployed to Oregon Hospital and Texas-Based Industrial Facility
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new deployment and another contract renewal, which both utilize the company’s K5 ASR. The announcement reads, “An Oregon healthcare organization with more than 70 primary care, specialty and urgent care clinics; a hospital; a children’s…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Upcoming H.C. Wainwright Conference
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that its CFO Ryan Confer will be providing an overview of the company’s pioneering gene therapies for cancer and diabetes at the upcoming H.C. Wainwright 25th Annual Global Investment Conference. Confer’s presentation is scheduled…
-
MissionIRNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article
Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup and 420.com brands and their respective domain names. In exchange, High Times will receive a…
-
MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Releases First ESG Report
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has published its first-ever environmental, social and governance report. CNIKF’s 2022 Environmental, Social and Governance report contains key disclosures that the company is providing in accordance with the Global Reporting Initiative: Core Option. The report also contains an…
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Featured in The New Stack Article Discussing Potential Impact of Quantum Computing on AI
D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, was spotlighted in a recent article from The New Stack titled “D-Wave Suggests Quantum Annealing Could Help AI.” The article notes that the effect of quantum computing on artificial intelligence (“AI”) could be as understated as it is profound. According to the…
-
MissionIRNewsBreaks – Why RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’
RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, available by prescription for the treatment of acquired blepharoptosis (low-lying eyelid(s)) in adults. “UPNEEQ(R) (‘RVL-1201’) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (‘FDA’) for acquired blepharoptosis. The company…
-
MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Releases Status Update on Company Activities
Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, has released an update regarding recent activities. The update noted new management announcements as well as a $12 million loan facility. According to the report, Canada Nickel has added three key personnel to its management team. Desmond Tranquilla will…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Rebrands as Scinai Immunotherapeutics Ltd.
BiondVax (NASDAQ: BVXV), a biotechnology company, today announced a change of its corporate name to Scinai Immunotherapeutics, which will debut on the Nasdaq under a new symbol, SCNI, on Sept. 7, 2023. In the past two years, the company has revamped its senior management team and pharmaceuticals development programs and recently announced its expansion into…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Record Capacity Levels for Fr8Fleet
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company offering its custom-developed Fr8App, an industry-leading freight-matching platform that offers a B2B cloud-based solution for cross-border and domestic shipping within the USMCA region. The company reported a record number of active carriers in its Fr8Fleet brand at end of August 2023, an increase of 60.8% versus…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP), RippleLink Partner to Provide Private LTE, Enhanced Connectivity to ASR Customers
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is collaborating with RippleLink, a Private LTE systems integrator. The partnership will provide Private LTE design and deployment services designed to offer “blazing fast” connectivity with Knightscope’s ASR service when using traditional, public-use cellular service. According to the…
-
MissionIRNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present at Upcoming H.C. Wainwright Global Investment Conference
Longeveron (NASDAQ: LGVN, LGVNR), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-related Frailty, today announced that its management will be participating in the 25th Annual H.C. Wainwright Global Investment Conference. The event is slated to take place in…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at Upcoming H.C. Wainwright Global Investment Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be presenting at the 25th annual H.C. Wainwright Global Investment Conference. The conference is slated for Sept. 11–13, 2023, in New York City. According to the announcement, CNS…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO to Present at Upcoming H.C. Wainwright Conference
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that it will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference taking place on Monday, Sept. 11, 2023. The announcement reads, “Knightscope’s Chairman and CEO, William Santana Li, will deliver a corporate overview followed…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs
BiondVax (NASDAQ: BVXV), a biotechnology company that recently signed an exclusive worldwide license to develop and commercialize innovative alpaca-derived nanosized antibodies (“NanoAbs”) targeting IL-17 cytokines as treatments for psoriasis and psoriatic arthritis, recently received coverage in analysis by Aegis Capital Corp. The report, which reiterated a buy recommendation and $70 target price for BVXV, contained…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Patent Protection in ‘Some of the Most Important Markets in the World’
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, recently received a patent from the China National Intellectual Property Administration. “The granted patent broadly covers the use of the company’s drug candidate REQORSA(R) immunogene therapy in combination with PD-1 antibodies, such as Keytruda(R), to treat…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 and K1 ASRs to Patrol New York-Based Pharmaceutical Facility
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new 7-robot contract with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. The new client subscribed to one K5 ASR assigned to patrol a 4-story garage…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Responds to Question Asked on ‘Making Money with Charles Payne’
Mullen Automotive’s (NASDAQ: MULN) CEO and Chairman David Michery appeared on “Making Money with Charles Payne” on Fox Business on Thursday, Aug. 31, to discuss the lawsuit against large brokerage firms for unlawful trading practices of the company’s stock and other matters. The company today announced its response to a question asked during Michery’s appearance…
-
MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Helping Implement Solutions Across Changing Financial Landscape
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a company formed to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. “With digital money replacing physical cash, consumers buy products and services from anywhere in the world, making payments across borders. FEXD plans to…
Search Articles
Latest Articles
- MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) and Secarna Report Positive Early Results From Antibody Oligonucleotide Collaboration
- MissionIRNewsBreaks – Residential Equity Strategy Gains New Context with TYTL’s Reg D Filing
- MissionIRNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Reports First S-K 1300 Indicated Resource, Hybrid Mining Estimate for Sarfartoq
- MissionIRNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on Expanding AI Infrastructure Investment
- VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program Beyond Discovery Phase